CHECK OUT OUR LIFE SCIENCES LATEST NEWSLETTER PUBLISHED IN DECEMBER BY THOMSON REUTERS IN PRACTICAL LAW

On 1 November 2017, the Tripartite Committee of Managers (CIT) published Resolution No. 29/2017 (Portuguese language), which requires public health physicians to justify any prescriptions of non-standardised drugs. Non-standardised drugs are drugs that are not included on the list of drugs provided by the Brazilian Public Health System (SUS).

Many lawsuits involving the supply of non-standardised drugs and general non-standardised drug prescriptions by physicians are currently running in the courts. The need to closely organise and centralise data regarding the prescription of such drugs is clearly indispensable to the SUS. In view of that, the new resolution provides that physicians must justify prescriptions in cases where: (i) the drug is non-standardised; or (ii) the drug is standardised but contraindicated or has no indication for the patient.

The CIT is a permanent forum for negotiation, communication and decision-making among public managers on operational aspects and construction of national, state and regional pacts in the SUS. The new resolution is expected to: (i) provide information on the prescription of non-standardised medicines in the SUS for the establishment of a national data bank; (ii) clarify the motivation and characteristics of non-standardised drug prescriptions; and (iii) subsidise the CIT with data for the definition and prioritisation of the drugs to be evaluated by the Brazilian Commission for the Incorporation of Technologies, which is known as CONITEC.

Source: Tripartite Committee of Managers: Resolution No. 29/2017 (Portuguese language).

“Reproduced from Practical Law with the permission of the publishers. For further information visit www.practicallaw.com or call +44 (0)20 7542 6664.”